XML 20 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flows from Operating Activities    
Net income $ 1,634 $ 1,251
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:    
Provisions for losses 775 573
Depreciation and amortization 348 296
Deferred taxes and other (254) 18
Stock-based compensation 84 89
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Other receivables 122 786
Other assets (85) 351
Accounts payable and other liabilities (431) (2,072)
Travelers Cheques and other prepaid products (130) (132)
Net cash provided by operating activities 2,063 1,160
Cash Flows from Investing Activities    
Sales of available-for-sale investment securities 0 0
Maturities and redemptions of available-for-sale investment securities 886 860
Purchase of investments (1,215) (1,294)
Net (increase) decrease in Card Member receivables and loans, including held for sale [1] 348 1,450
Purchase of premises and equipment, net of sales (237) (277)
Acquisitions/Dispositions, net of cash acquired (475) (28)
Net cash (used in) provided by investing activities (693) 711
Cash Flows from Financing Activities    
Net increase (decrease) in customer deposits 2,206 735
Net decrease in short-term borrowings (1,489) (1,941)
Issuance of long-term debt 3,984 8,420
Principal payments on long-term debt (7,203) (3,801)
Issuance of American Express preferred shares 0 0
Issuance of American Express common shares 11 31
Repurchase of American Express common shares (134) (926)
Dividends paid (324) (313)
Net cash provided by (used in) financing activities (2,949) 2,205
Effect of foreign currency exchange rates on cash and cash equivalents (178) 107
Net increase in cash and cash equivalents (1,757) 4,183
Cash, cash equivalents and restricted cash at beginning of period 33,264 25,494
Cash, cash equivalents and restricted cash at end of period $ 31,507 $ 29,677
[1]
(a) Refer to Note 2 for additional information.